Ayala Pharmaceuticals, Inc.

CIK: 0001100397

SEC Filings for Ayala Pharmaceuticals, Inc.

424B3 - Prospectus [Rule 424(b)(3)]

Form Type: 424B3

Filing Date: 2013-02-15

View Filing

424B3 - Prospectus [Rule 424(b)(3)]

Form Type: 424B3

Filing Date: 2013-02-15

View Filing

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]

Form Type: 10-K/A

Filing Date: 2013-02-14

View Filing

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Form Type: 10-K

Filing Date: 2013-02-13

View Filing

424B3 - Prospectus [Rule 424(b)(3)]

Form Type: 424B3

Filing Date: 2013-02-12

View Filing

NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405

Form Type: NT 10-K

Filing Date: 2013-01-30

View Filing

8-K - Current report

Form Type: 8-K

Filing Date: 2012-12-28

View Filing

8-K - Current report

Form Type: 8-K

Filing Date: 2012-12-21

View Filing

SC 13G - Statement of Beneficial Ownership by Certain Investors

Form Type: SC 13G

Filing Date: 2012-12-21

View Filing

424B3 - Prospectus [Rule 424(b)(3)]

Form Type: 424B3

Filing Date: 2012-12-14

View Filing